Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MOISES NEVAH RUBIN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1841482429
CMS profile
871203
Location
PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2020 · Entire year

$15,178.57

18 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2020 · entire year · sorted by reported total

By paying entity

PY2020 · entire year · sorted by reported total

Paying entityAmountRecords
Gilead Sciences, Inc. $8,954.91 9
Intercept Pharmaceuticals, Inc. $3,475.01 3
AbbVie Inc. $2,748.65 6

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MOISES NEVAH RUBIN

NPI 1841482429 · CMS profile ID 871203

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

PHOENIX, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1841482429?year=2020&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MOISES NEVAH RUBIN, NPI 1841482429, CMS profile ID 871203. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1841482429?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
APA 7
IndustryPayments. (2026). MOISES NEVAH RUBIN, NPI 1841482429, CMS profile ID 871203. General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1841482429?year=2020&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019.
Bluebook
MOISES NEVAH RUBIN, NPI 1841482429, CMS profile ID 871203, IndustryPayments, General Payments, PY2020; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–18 of 18 matching records. This page contains 18 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/a08c4b30-5cf3-4948-ad40-36f404619019. https://industrypayments.org/provider/npi-1841482429?year=2020&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2020 · Physicians and non-physician practitioners · CMS publication 2026-06-30

18 matching records · $15,178.57 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 18 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–18 of 18.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $400.0012/14/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821317 CMS
Intercept Pharmaceuticals, Inc. $750.0009/30/2020 Honoraria No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739858999 CMS
Gilead Sciences, Inc. $1,520.0009/28/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821315 CMS
Gilead Sciences, Inc. $400.0009/15/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821313 CMS
AbbVie Inc. $13.4105/01/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052093 CMS
Gilead Sciences, Inc. $400.0004/29/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821311 CMS
Intercept Pharmaceuticals, Inc. $125.0103/05/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739858987 CMS
Intercept Pharmaceuticals, Inc. $2,600.0003/05/2020 Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 739858995 CMS
Gilead Sciences, Inc. $3,030.0002/21/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821309 CMS
Gilead Sciences, Inc. $104.1402/20/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747991693 CMS
AbbVie Inc. $18.4002/12/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052091 CMS
AbbVie Inc. $2,500.0002/04/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052089 CMS
AbbVie Inc. $110.0001/30/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052087 CMS
AbbVie Inc. $3.8201/24/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052085 CMS
Gilead Sciences, Inc. $3,030.0001/24/2020 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743821307 CMS
Gilead Sciences, Inc. $32.2001/24/2020 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 743825669 CMS
Gilead Sciences, Inc. $38.5701/23/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 747991691 CMS
AbbVie Inc. $103.0201/22/2020 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 722052083 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $59,635.30 87
PY2020 $15,178.57 18
PY2021 $18,907.58 30
PY2022 $19,882.90 38
PY2023 $15,174.43 33
PY2024 $4,786.47 7
PY2025 $49,547.39 29

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $19,500.00 4
PY2023 Principal investigator $29,505.42 7
PY2022 Principal investigator $70,414.20 13
PY2021 Principal investigator $126,077.21 46
PY2020 Principal investigator $152,434.56 76
PY2019 Principal investigator $182,372.66 59

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

59 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,874.82 12/19/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702081905
Principal investigator 1 Intercept Pharmaceuticals, Inc. $48.00 12/12/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702081025
Principal investigator 1 Intercept Pharmaceuticals, Inc. $625.95 11/13/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011507 No dispute reported 06/30/2026 702079487
Principal investigator 1 Intercept Pharmaceuticals, Inc. $13,054.47 10/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702079009
Principal investigator 1 Allergan Inc. $2,090.00 10/16/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE
Open-label Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis NASH No dispute reported 06/30/2026 670085887
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,519.83 10/09/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702077737
Principal investigator 1 Intercept Pharmaceuticals, Inc. $12,452.45 09/19/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702077155
Principal investigator 1 Intercept Pharmaceuticals, Inc. $4,607.46 08/27/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702076333
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,835.80 08/22/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702075695
Principal investigator 1 Intercept Pharmaceuticals, Inc. $903.90 08/15/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011507 No dispute reported 06/30/2026 702075437
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,519.83 07/24/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702074671
Principal investigator 1 Allergan Inc. $2,242.00 07/18/2019 Non-covered Recipient Entity
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
OPEN-LABEL ROLLOVER STUDY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS NASH No dispute reported 06/30/2026 670059009
Principal investigator 1 Intercept Pharmaceuticals, Inc. $10,256.95 07/18/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702074377
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,303.73 06/19/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702073459
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,690.00 06/19/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702073463
Principal investigator 1 Intercept Pharmaceuticals, Inc. $10,910.68 06/18/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702072895
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 06/13/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702072381
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 06/13/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702072386
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,002.00 05/29/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011507 No dispute reported 06/30/2026 702072179
Principal investigator 1 Intercept Pharmaceuticals, Inc. $8,550.98 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071469
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071475
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071479
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071484
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071487
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071491
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071493
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071505
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071509
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071519
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 05/23/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702071525
Principal investigator 1 Intercept Pharmaceuticals, Inc. $625.95 05/14/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011507 No dispute reported 06/30/2026 702070753
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,519.83 04/26/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702070242
Principal investigator 1 Intercept Pharmaceuticals, Inc. $3,182.40 04/15/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702069855
Principal investigator 1 Allergan Inc. $350.00 04/11/2019 Non-covered Recipient Entity
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
OPEN-LABEL ROLLOVER STUDY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS NASH No dispute reported 06/30/2026 670037439
Principal investigator 1 Dova Pharmaceuticals $2,600.00 04/09/2019 Covered Recipient Teaching Hospital
UT MD ANDERSON CANCER CENTER
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420741
Principal investigator 1 Intercept Pharmaceuticals, Inc. $2,303.73 04/05/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702069223
Principal investigator 1 Intercept Pharmaceuticals, Inc. $6,500.00 04/03/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1009742 No dispute reported 06/30/2026 702068539
Principal investigator 1 Intercept Pharmaceuticals, Inc. $14,732.24 03/26/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702068303
Principal investigator 1 Dova Pharmaceuticals $250.00 03/14/2019 Non-covered Recipient Entity
Western Institutional Review Board Inc
Phase 3b open-label, multicenter study to evaluate the safety and efficacy of avatrombopag in subjects with thrombocytopenia scheduled for operations to critical sites or operations with a high risk of bleeding. No dispute reported 06/30/2026 689420651
Principal investigator 1 AbbVie, Inc. $2,700.00 03/11/2019 Non-covered Recipient Entity
University Of Texas Health Science Center At Houston
M16-135 No dispute reported 06/30/2026 647609521
Principal investigator 1 Intercept Pharmaceuticals, Inc. $6,392.96 02/14/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702065735
Principal investigator 1 Intercept Pharmaceuticals, Inc. $3,137.32 02/07/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011507 No dispute reported 06/30/2026 702065401
Principal investigator 1 Allergan Inc. $1,300.00 01/31/2019 Non-covered Recipient Entity
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
OPEN-LABEL ROLLOVER STUDY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS NASH No dispute reported 06/30/2026 670021081
Principal investigator 1 Intercept Pharmaceuticals, Inc. $18,831.34 01/24/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702064391
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/22/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702064085
Principal investigator 1 Allergan Inc. $4,484.00 01/15/2019 Non-covered Recipient Entity
THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT H
OPEN-LABEL ROLLOVER STUDY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS NASH No dispute reported 06/30/2026 670016615
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063872
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063881
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063887
Principal investigator 1 Intercept Pharmaceuticals, Inc. $495.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063891
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063895
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063901
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063905
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063911
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063915
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063921
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063927
Principal investigator 1 Intercept Pharmaceuticals, Inc. $1,320.00 01/10/2019 Non-covered Recipient Entity
UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON
1011866 No dispute reported 06/30/2026 702063933
Principal investigator 1 Novartis Pharmaceuticals Corporation $1,799.04 01/01/2019 Non-covered Recipient Entity
UT HEALTH SCIENCE CENTER
A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED 2 PART ADAPTIVE DESIGN MULTICENTER 12 WEEK STUDY TO ASSESS SAFETY TOLERABILITY AND EFFICACY OF LJN452 IN PATIENTS WITH NON ALCOHOLIC STEATOHEPETATIS NASH No dispute reported 06/30/2026 640730313